Home > Chemicals & Materials > Specialty Chemicals > Custom Synthesis > Choline Bitartrate Market
Choline Bitartrate Market Size
- Report ID: GMI5241
- Published Date: Mar 2022
- Report Format: PDF
Choline Bitartrate Market Size
Choline Bitartrate Market size exceeded USD 410 million in 2021 and is estimated to grow at over 6% CAGR between 2022 and 2028. Choline bitartrate is an active pharmaceutical ingredient formed by the mixture of choline and tartaric acid. Choline is an essential nutrient precursor to acetylcholine. It helps in synthesis of sphingomyelin and phosphatidylcholine which major constitutes of cell membrane. Choline bitartrate plays an important role in lipid transportation, supports cell membrane, healthy metabolism, DNA synthesis and early brain development.
Choline bitartrate is used in place of natural choline as it is easily digestible and has better immersion rate. There are three types of choline bitartrate namely choline d-bitartrate, choline l-bitartrate and choline dl-bitartrate. Increasing acceptance of it in infant formula, dietary supplements, fortified food & beverage industry is expected to drive choline bitartrate market demand. Rising awareness regarding essential nutrition and growing emphasis on preventive health care will propel the demand for choline bitartrate in upcoming years.
| Report Attribute | Details |
|---|---|
| Base Year: | 2021 |
| Choline Bitartrate Market Size in 2021: | 410.2 Million (USD) |
| Forecast Period: | 2022 to 2028 |
| Forecast Period 2022 to 2028 CAGR: | 6% |
| 2028 Value Projection: | 620 Million (USD) |
| Historical Data for: | 2017 to 2028 |
| No. of Pages: | 200 |
| Tables, Charts & Figures: | 175 |
| Segments covered: | Type, Application |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Covid-19 pandemic enforced manufacturing units and factories to shut down temporarily this factor significantly hampered manufacturing operations of the choline bitartrate market. However, as food & beverages, pharmaceuticals, and nutritional supplements were considered as an essential commodity, their production continued during pandemic by taking precautionary measures. This factor caused a demand and supply gap between manufacturers and raw material suppliers which affected the overall market growth.
Various regulations and standard specifications for the quality, labelling, advertisement, and formulation, of choline bitartrate for the usage in food products is anticipated to hinder the market growth at some extend. For instance, EU (EU) No 609/2013 prohibits the use of infant’s pictures for presentations, packaging and advertising of infant formula. It also states that any text or picture should not idealize use of such formula. Advertising and labeling for infant formula should be designed in such a way that it does not discourage breast-feeding.
Frequently Asked Questions (FAQ) :
Choline Bitartrate Market Scope
